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TypeVII collagen is the major component of anchoring
¢brils within the cutaneous basement membrane zone.
The large amino-terminal noncollagenous domain of
type VII collagen interacts with various extracellular
matrix proteins and contributes to the dermal^epider-
mal attachment.The purpose of this study was to detect
alternative splicing of COL7A1 transcript encoding the
noncollagenous 1 domain. The alternative splicing in
this region may a¡ect interactions of the noncollagen-
ous 1 domain with extracellular matrix proteins and
also dermal^epidermal adhesion.Thus we examined ex-
pression of the alternative splicing in situations relating
to wound healing and skin remodeling that required
dermal^epidermal binding and detachment. Ampli¢ca-
tion of overlapping cDNA from keratinocytes using
reverse transcription^polymerase chain reaction identi-
¢ed alternative splicing, which was generated by a dif-
ferent exon 18 acceptor site 27 bp upstream from the
common acceptor site. Expression of this alternatively
spliced transcript di¡ered among several cell types.
The nine amino acid residues GPLTLPLSP from the
27 bp nucleotides were inserted into the linker of ¢bro-
nectin type III domains.This insertion was suggested to
contribute to £exibility of the linker of ¢bronectin type
III domains and may a¡ect the interactions between the
noncollagenous 1 domain and extracellular matrix pro-
teins. Treatment with transforming growth factor-b 1,
which is known to promote wound healing and skin re-
modeling, enhanced the expression of this 27 bp tran-
script. Furthermore, keratinocyte biopsies from the
wound edge of patients with epithelizing skin ulcers
showed a signi¢cant increase in the 27 bp transcript ex-
pression compared with normal keratinocytes from
steady-state body sites. These results suggest that amino
acid variation of this alternative splicing may have some
role in dermal^epidermal adhesion, wound healing,
and skin remodeling. To the best of our knowledge, this
is the ¢rst evidence of alternative splice insertion of a
small peptide into the linker region of the ¢bronectin
type III domains, a common motif within modular
proteins. Key words: dermal^epidermal adhesion/keratino-
cyte/skin remodeling/transforming growth factor-b/wound
healing. J Invest Dermatol 120:942 ^948, 2003
T
ypeVII collagen, a non¢brillar collagen, is the major
component of anchoring ¢bril attachment structures
below the epidermal basement membrane (Uitto
et al, 1992; Burgeson, 1993). Type VII collagen
comprises three identical a chains, [a1(VII)]3, each
consisting of a 145 kDa central collagenous triple-helical domain
characterized by Gly-X-Y repeats, £anked by a 145 kDa amino-
terminal noncollagenous domain (NC1), and a smaller 34 kDa
carboxyl-terminal noncollagenous domain (NC2) (Lunstrum et
al, 1987). Cloning of type VII collagen cDNA has demonstrated
a primary sequence of 2944 amino acids, the organization of the
putative functional domains (Christiano et al, 1994a), and subse-
quent genomic cloning has highlighted the structural organiza-
tion of the type VII collagen gene (COL7A1) (Christiano et al,
1994b). This cloning information has enabled genomic DNA
sequence analysis for COL7A1 and demonstrated that mutations
within COL7A1 are associated with the dystrophic forms of epi-
dermolysis bullosa, a group of mechanobullous diseases charac-
terized by cutaneous fragility and tendency to form sub-basal
lamina densa blisters (Christiano and Uitto, 1996; Pulkkinen and
Uitto, 1999; Chen et al, 2002). In addition, targeted disruption of
COL7A1 in a mouse model showed an identical phenotype to the
dystrophic form of epidermolysis bullosa in humans (Heinonen
et al, 1999). Therefore, these results indicate that type VII collagen
is of critical importance for integrity of the cutaneous basement
membrane zone.
Expression of COL7A1 is modulated by various factors includ-
ing cytokines and ultraviolet, and promoter analysis of the gene
has detected several cis-acting elements in 50 -£anking region of
COL7A1 (Mauviel et al, 1994; Chen et al, 1997a; Kon et al, 1999).
Modulation of COL7A1 expression should result in a change in
dermal^epidermal adhesion, and may be involved in remodeling
of the epidermal architecture. The NC1 domain of type VII col-
lagen has been shown to interact with various extracellular ma-
trix (ECM) proteins, including ¢bronectin, laminin 5, and type I
and IVcollagens (Chen et al, 1997b). Modulation of the properties
of the NC1 domain may also vary the dermal^epidermal attach-
ment that may occur in both physiologic and pathologic skin
conditions.
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Alternative splicing enables the generation of various gene
products with di¡erent functions from a single gene, and is regu-
lated in a cell-speci¢c, tissue-speci¢c, and development stage-spe-
ci¢c manner. Alternative splicing of genes coding ECM proteins,
including the collagens occurs frequently and is thought to have
important functional implications (Breitbart et al, 1987); however,
alternative splicing in COL7A1 has not, as yet, been reported.
There is a possibility that alternative splicing of COL7A1may af-
fect changes in the stability in the dermal^epidermal junction and
may be involved in wound healing and skin remodeling.
The purpose of this study was to identify alternative
splicing COL7A1 transcripts arising within the NC1 domain.
Furthermore, if there is, we examined expression of the
alternative splicing in situations relating wound healing and skin
remodeling.
MATERIALS AND METHODS
Cell culture Normal human epidermal keratinocytes (NHEK)
(Clonetics, San Diego, CA) were cultured in serum-free, low calcium
(0.15 mM), keratinocyte growth medium supplemented with 0.1 ng
epidermal growth factor per ml, 0.5 mg hydrocortisone per ml, 5 mg
insulin per ml, 150 mg bovine pituitary extract per ml, and antibiotics (50
mg gentamicin per ml) (Clonetics). Normal human ¢broblast (NHF)
cultures, established by explanting tissue specimens obtained from
adult skin, were cultured with Dulbecco’s modi¢ed Eagle’s medium
supplemented with 10% fetal bovine serum and antibiotics (100 units per
ml penicillin-G, 0.1 mg streptomycin per ml) and utilized in passages 3^6
for experiments. Transformed human keratinocyte cell line, HaCaT cells
(Boukamp et al, 1988), and a human amnion derived cell line,WISH cells,
were maintained with the same medium as NHF. For upregulation
of COL7A1 expression, transforming growth factor(TGF)-b1 (Roche
Molecular Biochemicals, Mannheim, Germany) was added to the culture
medium to make a ¢nal concentration of 5 ng per ml.
Primers for COL7A1 The primer sets were synthesized for
ampli¢cation of COL7A1 cDNA, based on the sequence of the mRNA
(GenBank/EMBL Data Bank accession number, L02870) (Christiano et al,
1994a). These primers are shown in Table I, in which the nucleotide
number started from the adenine of the initial codon. The primer sets
from 1 to 21 were for the region encoding the NC1 domain. Primer set
C7 was designed for ampli¢cation of the 30 end of COL7A1mRNA. The
primer for alternative region 10AS was 50 -accccttaccttgcctctgt-30. The
control primers for glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
were also shown inTable I.
Ampli¢cation of COL7A1 cDNA Total RNA was extracted from
cultured cells using an RNeasy RNA extraction kit (QIAGEN, Hiden,
Germany) according to the manufacturer’s protocol. First strand cDNA
was synthesized with reverse transcriptase (Life Sciences Inc., St
Petersburg, FL) using an oligo-dT primer. Polymerase chain reaction
(PCR) was carried out basically using a repeating cycle at 941C for 45 s,
56^611C for 45 s, and 721C for 60 s with recombinant Taq-DNA
polymerase (Takara, Kyoto, Japan). Appropriate volumes (3^12 ml) of the
PCR products were fractionated by 2% agarose gels and stained with
ethidium bromide. The amount of PCR product was measured as the
intensity of the band by densitometry. The PCR conditions were
determined using an oligo-dT-primed HaCaT cDNA and the full-length
COL7A1 cDNA clone (Sawamura et al, 2002). The annealing temperature
of the PCR reaction was optimized by changing the conditions to suit
each primer set (Table I). The number of PCR cycles was between 29
and 34, and we established the number that was required for each primer
set and plotted this against £uorescence intensity to ensure that
experiments were done within the exponential phase of the PCR. For
each experiment, the constitutive ^GAPDH mRNA was used as a
standard reference transcript and was present at equivalent levels in all
RNA samples.
Alternative splicing in keratinocytes from the skin ulcer The skin
samples were collected from six patients with skin ulcers resulting from
trauma and deep dermal burn treatment at the Hokkaido University
Hospital. Informed consent was obtained from individual subjects in
accordance with procedures approved by Hokkaido University Graduate
School of Medicine Ethics Committee for Research on Humans. We
selected the patients with epithelizing ulcers at the healing stage, but the
ulcer was so large that complete epithelization was expected to take a
considerable time and to lead to hypertrophic scar formation. During
operations we removed the skin samples from the ulcer with 0.5 cm
margin, and keratinocytes were obtained from these samples. Normal
skin samples were obtained from seven patients undergoing reconstructive
plastic surgery. Epidermal sheets were obtained from the skin samples by
treatment with 10 mg dispase per ml (3 h at 371C) (Sawamura et al, 1998).
Keratinocyte suspensions were obtained from these epidermal sheets by a
further 0.25% trypsin treatment (30 min at 371C) and subjected to an
RNeasy RNA extraction kit (QIAGEN). Ampli¢cation of COL7A1
cDNAwas performed as described above.
Table I. The primer sets are used for PCR experiments. The nucleotide number started from the adenine of the initial start
codon. The annealing temperature (AT) for each primer set was shown.
Set Region Forward primes Revere primers AT
1 1-331 1F; 50 -atgacgctgcggcttctggtgg-30 1R; 50 -taagctcacggatggcgcggat-30 58
2 272-490 2F; 50 -agttcggcctggatgcactt30 2R; 50 -tcagcctttgggcagctgtg-30 56
3 435-847 3F; 50 -cctgatcacagacgggaagt-30 3R; 50 -cctcctgccgctcactcggc-30 58
4 788-1176 4F; 50 -aggtccagtacactcctctg-30 4R 50 -ctcatagtccgtgccaggctcca-30 56
5 1120-1424 5F; 50 -ggccctgggcagggttcagtgt-30 5R; 50 -ccaactggtagcgggtcacatcaga-30 61
6 1369-1631 6F; 50 -ccgcagaaggtggtactgcc-30 6R; 50 -gtgctgcgcacaatgatgcggta-30 58
7 1531-1890 7F; 50 -gtaacagacctgcaagccac-30 7R; 50 -gctaatccgaaatccactgg -30 56
8 1789-2130 8F; 50 -actccacttgctgttccagg-30 8R; 50 -aggaaccctggtccaggtaa-30 56
9 1891-2254 9F; 5’-tggagcacaggcagtggtcc-30 9R; 50 -gcaccgtatactcagtatctgg-30 56
10 2173-2474 10F; 50 -ccagagaaatcccagttggt-30 10R; 50 -tttcctgggagtatctggtg-30 56
11 2251-2610 11F; 50 -gtgcatgtgagggcccatgt-30 11R; 50 -cagggctggcggagcctcag-30 58
12 256102814 12F; 50 -cacctgtctccattgttgtc-30 12R; 50 -ccctaggacactcagcctca-30 56
13 2745-2970 13F; 50 -gctcagcagctatcacctgg-30 13R; 50 -ccgccaggataggatgtagc-30 56
14 2846-3210 14F; 50 -ctgcgcgcactgagtcacctcgtgt-3 14R; 50 -ctccgcacggtgagcattgt-30 59
15 2971-3330 15F; 50 -ccactcagaggccctggcca-30 15R; 50 -gccattcagtgggaacagtg-30 56
16 3271-3561 16F; 50 -gttcaggttggcctgctgtc-30 16R; 50 -cacattaagcccagaagcct-30 55
17 3488-3810 17F; 50 -tgctagtggatgaacccttg-30 17R; 50 -aggcccaacttgtcctctca-30 56
18 3750-3984 18F; 50 -ttgtccaaagggccagaaggg-30 18R; 50 -tggagagccctttaggccag-30 57
19 3943-4291 19F; 50 -aatcctgggacccctgga-30 19R; 50 -ttccgggaagacccggcagcc-30 59
20 4099-4444 20F; 50 -aaaggggaccctggaccatc-30 20R; 50 -ggtcacctttggggccaata-30 56
21 4335-4647 21F; 50 -agaaaaaggtgactctgagg-30 21R; 50 -aacagcaggtcccaccactgca-30 56
C7 8070-8394 C7F; 50 -gccaggccccaagggtgacca-30 C7R 50 -gcacagcatggagctgggag-30 56
GAPDH GAF; 50 -tcatctctgccccctctgct-30 GAR; 50 -cgacgcctgcttcaccacct-30 55
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RESULTS
Alternative splicing is detected in COL7A1 First, we
determined PCR conditions, including optimal annealing
temperature and PCR cycles. Typical PCR experiments using an
oligo-dT-primed cDNA of HaCaT cells for primer sets of 10, C7,
and GAPDH shown in Fig 1, and in these cases PCR cycles were
¢xed at 34, 32, and 29, respectively.We extracted mRNA from
cultured NHEK and ampli¢ed overlapping cDNA encoding the
NC1 domain of type VII collagen using reverse transcriptase^
PCR, based on the determined conditions. The expression level
of typeVII collagen is relatively low, therefore we added TGF-b1
to increase COL7A1 expression to make the PCR ampli¢cation
of the cDNA easier. Northern blot analysis of NHEK mRNA
using a COL7A1 cDNA probe showed only a 9 kb single band
(data not shown), suggesting that no alternative mRNA splicing
leads to a change of more than 0.5 kb in size.We synthesized 21
sets of forward and reverse PCR primers to amplify less than
0.5 kb of overlapping cDNA (Table I). PCR ampli¢cation using
the primers 10F and 10R clearly demonstrated two bands of
approximately 300 and 330 bp in lane 10, whereas only single
bands were found in the other primer sets (Fig 2). As the primer
set 10 was predicted to amplify a 302 bp fragment of COL7A1
cDNA, the upper band was thought to contain an insertion
sequence, suggesting the existence of an alternative insert located
within the regions extending from nt2173 to 2474 of the
mRNA.
Sequence analysis of the PCR product revealed that the upper
fragment included a 27 bp insert at the 50 end. Comparison of the
Figure1. Determination of optimal cycles for PCR reactions. We
established the number of the cycles that was required for each primer set
and plotted this against £uorescence intensity to ensure that experiments
were done within the exponential phase of the PCR.Typical PCR experi-
ments using a oligo-dT-primed cDNA of HaCaTcells for primer sets of 10,
C7, and GAPDH shown and in these cases PCR cycles were ¢xed at 34, 32,
and 29, respectively.
Figure 2. Alternative splicing transcript is detectable in COL7A1.
We synthesized 21 sets of forward and reverse PCR primers that amplify
overlapping cDNA encoding the NC1 domain of type VII collagen. We
extracted mRNA from cultured NHEK and performed reverse transcrip-
tase^PCR. Two bands were only visible in lane 10, whereas, single bands
were identi¢ed using the other primer sets. M: 100 bp DNA marker.
Figure 3. Mechanism to generate an alternative splicing transcript. Comparison of the mRNAwith the gene of typeVII collagen demonstrated that
this alternative splicing was generated by another acceptor site (red arrow) of exon 18 at 27 bp upstream from the common acceptor site (black arrow).We
designated the usual shorter and the alternative longer transcripts as AS1 and AS2, respectively. The alternative spliced transcript inserted an additional nine
amino acid residues, GPLTLPLSP. Location of the primers 10F, 10R, and 10AS are indicated.
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mRNAwith the gene of typeVII collagen demonstrated that this
alternative splicing was generated by another acceptor site within
exon 18 at 27 bp upstream from the common acceptor site
(Fig 3). We designated the usual shorter and the alternative
longer transcripts as AS1 and AS2, respectively. The alternative
splicing inserted nine amino acid residues, GPLTLPLSP, into the
NC1 domain of type VII collagen, but did not alter the
downstream coding frame.
Expression of alternative transcript di¡ers among several
cell types Type VII collagen is known to be expressed by
NHEK and NHF, and also by cell lines such as HaCaT and
WISH cells, which were derived from keratinocytes and
amniotic cells, respectively. We extracted RNA from various
cultured cells and performed reverse transcriptase^PCR with
primers 10R and 10AS, the latter of which was designed to
hybridize speci¢cally with the 27 bp alternate insert (Fig 3).
As the expression level of COL7A1 mRNA could be used as
a reference for evaluating the alternative splicing, we also
synthesized a primer set C7 that ampli¢ed the 30 end of
COL7A1 mRNA. The primers for GAPDH were used as
controls. The annealing temperature and PCR cycles for primers
10R and 10AS were 571C and 341C, respectively. The result
showed that the AS2 transcript was found in cultured NHEK
andWISH cells, whereas cultured NHF and HaCaT cells showed
none or little of this AS2 transcript (Fig 4). COL7A1 expression
was detected in all samples, although that of the HaCaT cell line
was relatively low adjusting for similar levels of GAPDH
expression as standard. These results indicate that the AS2
expression is varied between di¡erent cell types.
Additional amino acid residues from alternative splicing is
inserted into the linker of ¢bronectin type III (FN3)
domain The central part of the NC1 domain consists of nine
repeating FN3 domains (Christiano et al, 1994a). Figure 5 shows
the multiple alignments of the nine FN3 domains of type VII
collagen using a Parallel Protein Information Analysis system
(Akiyama et al, 1998). The FN3 domains from type VII collagen
possessed the conserved seven b-strands (Fig 5). A b-barrel
structure was predicted to be formed by characteristic b-
sandwich fold with one b-sheet from four strands (G, F, C, C0)
and one from three strands (A, B, E). The nine residues
GPLTLPLS from the alternative splicing did not interfere with
the conserved structure of these strands, and was inserted into
the linker between the sixth and seventh FN3 domains (Fig 5).
TGF-b promotes alternative splicing TGF-b has been shown
to be a potent inducer of COL7A1 expression and consists of
three isoforms. TGF-b1 and TGF-b2 have similar biologic
activities and both can upregulate COL7A1 expression
(Ryynanen et al, 1991). When detecting the alternative splicing,
we treated NHEKwith TGF-b1 to enrich COL7A1mRNA.We
then examined whether TGF-b1 increased the level of AS2
Figure 4. Expression of alternative transcript di¡ers between cell
types. We extracted RNA from NHEK (1), HaCaT cells (2), NHF (3),
and WISH cells (4), and examined the expression levels of AS2, CO7A1,
and GAPDH using reverse transcriptase^PCR with primers 10R and
10AS, C7F and C7R, and GAF and GAR, respectively. The AS2 transcript
was found in cultured NHEK andWISH cells, whereas cultured NHF and
HaCaT cells showed no or little transcript.
Figure 5. Additional residues from alternative splicing are located within the linker region of the ¢bronectin type III (FN3) repeats. Multiple
alignment of nine FN3 repeats of type VII collagen showed that each FN3 repeat possessed the conserved seven b-strands (A,B,C,C0,E,F,G). The inserted
nine amino acid residues GPLTLPLSP (underlined) did not interfere with the conserved structure of these strands, and the insertion was integrated into the
linker between sixth and seventh FN3 repeats. Residues in red are identical in all nine repeats, in yellow are identical in at least seven repeats.
ALTERNATIVE SPLICING IN COL7A1 945VOL. 120, NO. 6 JUNE 2003
transcripts in cultured NHEK and NHF.We prepared RNA from
NHEK and NHF after TGF-b1 treatment at a concentration of
5 ng per ml, which was high enough to induce COL7A1
expression, and performed reverse transcriptase^PCR using
primer set 10. The results demonstrated that TGF-b1 increased
the intensity of both the lower (AS1) and upper (AS2) bands,
and the induction of the AS2 band was clearly higher than that
in the AS1 band (Fig 6A). Furthermore, reverse transcriptase^
PCR using primers 10R and 10AS for the AS2 transcript and
primer C7 set for COL7A1 con¢rmed that TGF-b1 enhanced
the expression of AS2 transcript more than COL7A1 (Fig 6A).
Semiquanti¢cation of the band intensity by densitometry
signi¢cantly con¢rmed the level of induction of AS2 was
approximately two times higher than that of COL7A1 for both
NHEK and NHF (Fig 6B).
AS2 transcript is increased in keratinocytes from the skin
ulcer Next, we determined what role the alternative splicing
has in wound healing and skin remodeling. We selected six
patients with skin ulcer resulting from trauma and deep dermal
burn and con¢rmed that normal epithelization occurred at the
wound margin.We obtained the skin biopsies from the margin
and assayed the expression levels of the alternative transcript
AS2 in these keratinocytes. Control skin samples were obtained
from seven normal individuals. Keratinocytes in the ulcer skin
samples clearly expressed higher levels of AS2 transcript than
those from the control samples, whereas the expression of
COL7A1 and GAPDH standard was similar between the ulcer
skin and the control (Fig 7). Semiquanti¢cation densitometry
analysis with correction of AS2 by COL7A1 expression showed
that AS2 expression of keratinocytes in the ulcer skin was
signi¢cantly higher than that of the control skin.
Figure 6. TGF-b promotes alterative splicing.We prepared RNA from
NHEK (K) and NHF (F) after treatment of TGF-b1 in a concentration of
5 ng per ml. (A) Reverse transcriptase^PCR was performed to examine
expression levels of alternative splicing (AS1 and AS2), AS2, COL7A1,
and GAPDH. (þ ), TGF-b1 was added; (^), negative control, no TGF-b1.
Typical experiment was shown. TGF-b1 increased the intensity of both
upper and lower bands (AS1 and AS2), although the level of induction in
the AS2 band was higher than that of the AS1 band. TGF-b1 enhanced the
expression of AS2 transcript more than COL7A1. (B) Semiquanti¢cation of
the band intensity by densitometry was performed. A signi¢cant induction
of the AS2 transcript was found byTGF-b1. The level of induction of AS2
was approximately 2-fold than that of COL7A1 in both NHEK and NFH.
Each value represents the mean7SD of three individual samples.
nSigni¢cant di¡erence in NHF; po0.05. nnSigni¢cant di¡erence in
NHEK; po0.05.
Figure 7. AS-2 transcript is upregulated in keratinocytes at the per-
iphery of skin ulcers.We selected six patients with skin ulcers after trau-
ma and deep dermal burn and checked that normal epithelization was
present at the margin of the ulcer. (A) We prepared RNA from keratino-
cytes at the margin of ulcer and assayed the expression levels of AS2,
COL7A1, and GAPDH using reverse transcriptase^PCR. Control skin
samples were obtained from seven normal individuals. Keratinocytes in
the ulcer skin samples clearly expressed higher levels of the AS2 transcript
than those in the control skin. (B) Semiquanti¢cation densitometry analy-
sis was performed.The ratio of AS2 per COL7A1 expression was calculated.
Each value represents the mean7SD. AS2 expression from the ulcer skin
was signi¢cantly higher than that of the control skin. nSigni¢cant di¡er-
ence, po0.01.
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DISCUSSION
Alternative splicing enables several gene products with di¡ering
functions to be produced from a single gene, and is one of the
most signi¢cant components of the functional complexity to the
human genome (Modrek and Lee, 2002). No report has identi¢ed
alternative splicing in COL7A1 to date, although alternative spli-
cing occurs frequently in genes coding ECM proteins, including
collagens and alternative splicing may have functional implica-
tions (Breitbart et al, 1987). The collagenous domains are common
to all collagen isoforms and each forms a characteristic triple he-
lical rod structure, whereas the noncollagenous domains are more
heterogeneous between di¡erent collagens and give unique mo-
lecular functions to each component.We hypothesized that there
would more likely be a functional alternative mRNA splicing in
the NC1 domain rather than the collagenous domain, and per-
formed reverse transcriptase^PCR using 21 sets of primers cover-
ing the entire NC1 domain.
Reverse transcriptase^PCR using mRNA from TGF-b1-trea-
ted keratinocytes identi¢ed an alternatively spliced variant that
contained an additional 27 nucleotides encoding nine amino acid
residues: GPLTLPLSP.The 27 bp nucleotides were inserted by the
skipping of a common splice acceptor site and usage of an alter-
nate acceptor site 27 bp upstream within the COL7A1NC1 do-
main. The correct open reading frame was restored in the
downstream cDNA. As alternative splicing can be regulated in a
cell- or tissue-speci¢c manner, we analyzed the alternative spli-
cing in the other cell types, including NHF, HaCaT cells and
WISH cells that express type VII collagen. The results demon-
strated that the AS2 transcript was found in cultured NHEK
and WISH cells, whereas cultured NHF and HaCaT cells ex-
pressed none or little. This di¡erence between di¡erent cell types
suggests that the alternative splicing is regulated in a cell-speci¢c
manner.
FN3 domain is a common motif within modular proteins and
is found in approximately 2% of all animal proteins.This domain
is characterized by the presence of a seven-stranded b-barrel
structure, which is thought to confer £exible or elastic properties
to this domain (Keller, 1997; Andres et al, 1998). The stretch-in-
duced unraveling of this domain contributes extensibility to the
molecule containing such domain. Individual type VII collagen
molecules form anti-parallel tail-to-tail dimers with a small
carboxyl-terminal overlap, and in the majority of molecules the
amino-terminal NC1 domains originate and terminate in the
lamina densa forming semicircular loop structures (Shimizu
et al, 1997). Extensibility of these FN3 repeats in the NC1 domain
may play a crucial part in the strength and elasticity at the inter-
face between the lamina densa and the dermis.
Figure 5 shows multiple alignments of nine FN3 domains of
typeVII collagen and all FN3 domains possessed these conserved
seven b-strands. The linker region of type VII collagen FN3 do-
main consists of between ¢ve and nine amino acids similar to
that of the typical FN3 domains ¢rst identi¢ed in ¢bronectin
(Sharma et al, 1999). This nine amino acid sequence is relatively
hydrophobic, and inserts into the linker between sixth and se-
venth FN3 domains maintaining the seven b-strand structure.
To our knowledge, this is the ¢rst study to identify such an alter-
native splicing insertion of this small peptide into the linker of
the FN3 domain. Similar alternative splicing has been reported
to insert three amino acids between the b-strand C and C0 of
FN3 domain in the collagen XIV gene (Imhof and Trueb, 1998).
It has been suggested that this increases the £exibility of the loop
between the two b-strands. The addition of the nine residues
(GPLTLPLSP) resulted in the amino acid number of the linker
region to increase from 8 to 17 (Fig 4).This linker region contains
an additional three proline residues that are critical for pivoting
and the £exibility of the many peptide chains.We also expect that
the nine residues contribute to £exibility of the linker of FN3
domains.
TGF-b is a potent regulator of cell growth and di¡erentiation,
and plays an important part during ¢brosis in normal and abnor-
mal conditions (Border and Noble, 1994). TGF-b induces the
synthesis of ECM proteins, including collagens and ¢bronectin,
and inhibits the synthesis of ECM-degrading enzymes. Further-
more,TGF-b promotes adhesion between cells and ECM by the
induction of integrins and increases the formation of new blood
vessels. Thus, these actions can help accelerate wound healing and
suggest a possible clinical use for TGF-b in treating skin ulcers
(Mustoe et al, 1987; Beck et al, 1990; Hirshberg et al, 2001). Re-
cently, TGF-b has been shown to control the di¡erentiation of
vascular smooth muscle cells, and reduces the ratio of smooth
muscle-speci¢c alternative splicing of the a-tropomyosin gene
in these cells (King-Briggs and Shanahan, 2000). Thus, we exam-
ined what e¡ect TGF-b1 has on the frequency of COL7A1 alter-
native splicing.These results demonstrated that TGF-b 1 increased
the expression of the AS2 transcript compared with the entire
COL7A1 gene expression and suggest that alternative splicing
might be involved in wound healing and skin remodeling.
Wound healing is closely regulated by a variety of soluble ef-
fectors, including growth factors, cytokines, proteases, anti-pro-
teases, and insoluble ECM components, and involves a
complicated network of interactions (Martin, 1997). Recent stu-
dies have shown that, in acute wound healing, type VII collagen
staining is observed in the wound bed and the neodermis, more-
over, the NC1 domain may have biologic roles in attracting or
maintaining adhering ¢broblasts to this region and promoting
the cellular remodeling of the wound bed into the newly formed
dermis (Haapasalmi et al, 1995;Woodley et al, 1988).Wound edge
keratinocytes migrate by repeatedly detaching and reattaching to
the cutaneous basement membrane zone. Thus, we examined the
alternative splicing in keratinocytes at the wound edge of skin
ulcers. Interestingly, the results showed a signi¢cant increase in
the AS2 transcript expression compared with normal, steady-state
keratinocytes. This suggests that the alternative splicing may have
some role in dermal^epidermal adhesion, wound healing, and
skin remodeling.
In conclusion, we have identi¢ed a novel alternative splicing
insertion of a small peptide into the linker region of the FN3 re-
peats in COL7A1. As precise diagnosis of the dystrophic form of
epidermolysis bullosa sometimes requires detection of COL71A
mutations, investigators involved in mutation analysis of the dys-
trophic form of epidermolysis bullosa should know this alterna-
tive splicing. In addition, we suggests that this amino acid
variation may a¡ect interactions between type VII collagen and
other ECM proteins, thereby providing a means for functional
regulation of dermal^epidermal attachment. This information
may be useful in understanding the role(s) of type VII collagen
in wound healing and skin remodeling, and aid the development
of new treatments for skin ulcers in clinical dermatology.
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